Allergy and COVID-19 Vaccines
NCT05028257
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
117
Enrollment
OTHER
Sponsor class
Conditions
Anaphylactic Reaction
Vaccine Reaction
Interventions
BIOLOGICAL:
COVID-19 Vaccines
Sponsor
Assistance Publique - Hôpitaux de Paris